Evidence-based benefit design: Toward a sustainable health care future for employers

Journal of Occupational and Environmental Medicine

Volumn 52, Issue 10, 2010, Pages 951-955

  Bunn, William B ^a,b   Stave, Gregg M ^c   Allen, Harris ^d   Naim, Ahmad B ^e  

^a Navistar International Corporation   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c DUKE UNIVERSITY   (United States)

^d Harris Allen Group LLC   (United States)

^e CENTOCOR INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABSENTEEISM; CLINICAL PROTOCOL; CONFIDENTIALITY; DECISION MAKING; EMPLOYEE; EMPLOYER; EVIDENCE BASED BENEFIT DESIGN; EVIDENCE BASED PRACTICE; HEALTH CARE COST; HEALTH CARE FINANCING; HEALTH CARE ORGANIZATION; HEALTH CARE PERSONNEL MANAGEMENT; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH PROGRAM; HEALTH STATUS; OCCUPATIONAL HEALTH; PRIVACY; PRODUCTIVITY; SHORT SURVEY; UNITED STATES; WORK CAPACITY; WORKMAN COMPENSATION;

EID: 77957985954     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/JOM.0b013e3181f72acb     Document Type: Article

References (24)

1. Chin D, Thompson M, Lutz S, Isgur B. Strong medicine required: prognosis for employer health care. New York, NY: PriceWaterhouseCoopers. 2009. Available at: http://www.pwc.com/us/en/view/winter09/employer-health care.jhtml. Accessed September 5, 2010.
2. Congressional Budget Office. Key issues in analyzing major health insurance proposals. Washington, DC: Congressional Budget Office. 2008. Available at: http://www.cbo.gov. Accessed September 5, 2010.
3. National Center for Chronic Disease Prevention and Health Promotion. Chronic disease overview. Atlanta, GA: Centers for Disease Control. 2008. Available at: http://www.cdc.gov/mmwr/distrnds.html. Accessed September 5, 2010.
4. Bunn W, Allen H, Stave G, Naim A. How to Align evidence-based benefit design with the employer bottom-line: a case study. J Occup Environ Med. 2010;52:956-963.
5. Montori V, Guyatt G. Progress in evidence-based medicine. JAMA. 2008;300:1814-1816.
6. Eddy D. Evidence-based medicine: a unified approach. Health Aff. 2005;24:9-17.
7. Tunis S. A conversation with David Eddy. Health Aff. 2007;26: w500-w515.
8. Greene J, Hibbard J, Murray J, Teutsch S, Berger M. The impact of consumer-directed health plans on prescription drug use. Health Aff. 2008;27:1111-1119.
9. Eddy D. "Investigational treatments: how strict should we be?" JAMA. 1997;278:179-185.
10. Lynch W, Gardner H. Aligning Incentives, Information, and Choice. Cheyenne, WY: Health as Human Capital Foundation; 2009.
11. Edington D. Zero Trends-Health as a Serious Economic Strategy. Ann Arbor, MI: University of Michigan Health Management Research Center; 2009.
12. Lerner D, Amick B, Rogers W, Malspeis S, Bungay K, Cynn D. Work limitations questionnaire. Med Care. 2001;39:72-85.
13. Kessler R, Ames M, Hymel P, et al. Using the World Health Organization health and work performance questionnaire (HPQ) to evaluate the indirect workplace costs of illness. J Occup Environ Med. 2004;46: S23-S37.
14. Edington D, Schultz A. The total value of health: a review of the literature. Int J Workplace Health Manage. 2008;1:8-19.
15. Goetzel R, Long S, Ozminkowsk R, Hawkins K, Wang S, Lynch W. Health, absence, disability, and presenteeism cost estimates of certain physical and mental health conditions affecting U. S. employers. J Occup Environ Med. 2004;46:398-412.
16. Austvoll-Dahlgren AAA, Aaserud M, Vist GE, et al. Pharmaceutical policies: effects of cap and co-payment on rational drug use. Cochrane Database Syst Rev. 2008: CD007017. DOI: 10.1002/14651858. CD007017.
17. Neumann P. Emerging lessons from the drug effectiveness review project. Health Aff. 2006;25: w262-w271.
18. McElwee N, Ho S, Kimberly A, McGuigan K, Horn M. Evidence-based coverage decisions: primum non nocere. Health Aff. 2006;25: w279-w282.
19. Goldman D, Joyce G, Zheng Y. Prescription drug cost sharing associations with medication and medical utilization and spending and health. JAMA. 2007;298:61-66.
20. Lynch W, Gardiner H. Part IV: business practices-a major, modifiable driver of healthcare costs (Entry 21). Health as Human Capital Foundation Blog. 2009. Available at: http://hhcf.blogspot.com. Accessed September 1, 2010.
21. Mahoney J. Reducing patient drug acquisition costs can lower diabetes health claims. Am J Manag Care. 2005;11: S170-S176.
22. Mahoney J, Hom D. BeneFIT Design: Seven Steps to Value-Based Health Benefit Decisions. Philadelphia, PA: GlaxoSmithKline; 2007.
23. Collins J, Baase C, Sharda C, et al. The assessment of chronic health conditions on work performance, absence, and total economic impact for employers. J Occup Environ Med. 2005;47:547-557.
24. National Committee for Quality Assurance. Healthcare effectiveness data and information set. 2011. Available at: http://www.ncqa.org. Accessed September 1, 2010.